Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
48.00    3.50 (7.87%)
Bid:
47.50
Ask:
48.50
Spread: 1.00 (2.105%)
Market Cap: £92.09m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

H1 2019 Update

12 Jul 2019 07:00

RNS Number : 2999F
Iofina PLC
12 July 2019
ย 

THE INFORMATION COMMUNICATED IN THIS ANNOUNCEMENT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014.

ย 

ย 

12 July 2019

ย 

Iofina plc

("Iofina", the "Group", or the "Company")

(LSE AIM: IOF)

ย 

H1 2019 Update

ย 

Iodine production up c.10 per cent; iodine price continues to climb

ย 

Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, today provides an update to the market regarding its activities during the first half of 2019.

In H1 2019, the Company produced a total of 286.7 metric tonnes ("MT") of crystalline iodine from its four IOsorbยฎ plants operating in Oklahoma, up 9.8 per cent from the prior year (H1 2018: 264.1 MT). Q2 output was significantly higher than Q1 production owing to the Q1 winter weather conditions and an efficiency fall at IO#6 previously detailed and now remedied. Iofina expects H2 2019 production from its current plants to total between 305-325 MT of crystalline iodine.

During the first half of the year, the Directors focused on securing additional capital and successfully raised ยฃ7.0 million of equity in Q2. The funds raised will be used to finance IO#8 plant construction and accelerate an upgrade programme at our existing plants These efforts will in turn increase iodine production and sales, as well as reduce the Company's debt. Simultaneously, $4.2m of debt was converted to equity by Southern Rock Insurance Company Limited.

The Group is pleased to confirm that the $3.3 million term loan facility was fully paid down at the end of June 2019. Together with the $4.2m debt for equity swap, the Company's debt has been reduced by $7.5 million, which has significantly strengthened the Group's financial position.

ย 

Iodine prices have continued to rise throughout the first half of 2019 due to tightness in supply in a market which continues to see solid demand. Iodine prices in the latter half of Q2 and into early Q3 are trending upward and most spot market iodine sales are now over $30/kg, a significant rise since this time last year, where spot iodine prices were approximately $25/kg at the start of Q3 2018.ย 

ย 

Additionally, IofinaEX has fully obtained its Industrial Hemp Processor/Handler License in the state of Kentucky. Research quantities of hemp have been procured and the Company will update the market on its progress in due course. IofinaEX will continue to explore global business opportunities in the CBD/cannabinoid market.

ย 

Iofina Chemical has continued to trade strongly in both iodine and non-iodine products.

ย 

Commenting, President and CEO Dr. Tom Becker stated: ''The Group had a strong start to the year, with many positive achievements including an almost 10% increase in iodine production year-on-year. Whilst this was accomplished through four operating IOsorbยฎ plants, we continue to evaluate options for a fifth plant, IO#8, which would significantly increase production rates in 2020.

ย 

"The successful fundraise in Q2 has enabled us to pay down our loan facility, and reduce debt further via a debt to equity exchange putting the Company in a stronger position. The iodine price continues to move in the right direction and we expect this to continue into the second half of the year.

ย 

"Iofina's newest subsidiary, IofinaEX, is now fully licensed to process hemp in the state of Kentucky and the Directors are committed to exploring the isolation of specialty chemical products from hemp, a rapidly expanding market."

ย 

Enquiries:

ย 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

ย 

Christopher Raggett/Giles Rolls/Matthew Radley (corporate finance)

Camille Gochez (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

ย 

Media Contact:

Charles Goodwin/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7544 275 882

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated Company that specialises in the production of Iodine and the manufacturing of specialty chemical products. As the second largest producer of iodine in North America, it comprises three entities; Iofina Resources, Iofina Chemical and IofinaEX.

Iofina Resources

Iofina Resources develops, builds, owns and operates iodine extraction plants using Iofina's WETยฎ IOsorbยฎ technology. Iofina currently operates four producing IOsorbยฎ plants in Oklahoma, and is consistently using technology and innovation to improve and expand its operations.

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals derived from raw iodine, as well as non-iodine based products for over 35 years.

IofinaEX

Iofina's newest subsidiary,ย IofinaEX,ย is now fully licensed to process hemp in the state of Kentucky and the Directors are committed to exploring the isolation of specialty chemical products from hemp, a rapidly expanding market.

www.iofina.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
ย 
END
ย 
ย 
TSTLLFFRDSILLIA
Date   Source Headline
24th May 20174:40 pmRNSSecond Price Monitoring Extn
24th May 20174:35 pmRNSPrice Monitoring Extension
24th May 201712:07 pmRNSSecond Price Monitoring Extn
24th May 201712:02 pmRNSPrice Monitoring Extension
19th May 20177:00 amRNSFinal Results and Notice of AGM
3rd May 20174:41 pmRNSSecond Price Monitoring Extn
3rd May 20174:35 pmRNSPrice Monitoring Extension
25th Apr 20174:40 pmRNSSecond Price Monitoring Extn
25th Apr 20174:35 pmRNSPrice Monitoring Extension
11th Apr 20177:00 amRNSTrading Update
3rd Apr 20177:00 amRNSProduction update
14th Feb 20174:35 pmRNSPrice Monitoring Extension
13th Jan 20177:00 amRNSCorporate Update
13th Dec 20164:35 pmRNSPrice Monitoring Extension
12th Dec 20167:00 amRNSCorporate update
2nd Dec 20167:00 amRNSChange of Registered Office
4th Nov 20167:00 amRNSDirectorate Change
13th Oct 20167:00 amRNSTrading Update
30th Sep 20167:00 amRNSCompletion of Debt Restructure
30th Sep 20167:00 amRNSInterim Results
12th Sep 20164:35 pmRNSPrice Monitoring Extension
17th Aug 20164:40 pmRNSSecond Price Monitoring Extn
17th Aug 20164:35 pmRNSPrice Monitoring Extension
11th Aug 20161:33 pmRNSWater Depot Permit Update
25th Jul 20164:40 pmRNSSecond Price Monitoring Extn
25th Jul 20164:35 pmRNSPrice Monitoring Extension
11th Jul 20167:00 amRNSCorporate and Production Update
7th Jun 201611:37 amRNSResult of AGM
7th Jun 20167:00 amRNSRestructure of Debt
9th May 20167:00 amRNSFinal Results and Notice of AGM
11th Apr 20167:00 amRNSMarket update
15th Feb 20167:00 amRNSDirectorate Change
18th Jan 20167:00 amRNSCorporate Update
14th Dec 20157:00 amRNSTrading Update
23rd Nov 20157:00 amRNSBrine Supply Update
28th Oct 20157:00 amRNSAppointment of CFO
15th Oct 20159:00 amRNSIofina becomes founding member of the WIA
9th Oct 20157:00 amRNSProduction and Corporate Update
5th Oct 20151:59 pmRNSChange of Registered Office
29th Sep 20157:00 amRNSInterim Results
14th Jul 20157:00 amRNSCorporate & Trading Update
22nd Jun 20155:41 pmRNSHolding(s) in Company
19th Jun 201512:05 pmRNSResult of AGM
16th Jun 20157:00 amRNSProduction Update
5th Jun 20157:00 amRNSWater Depot Permit Update
27th May 20157:00 amRNSFinal Results and Notice of AGM
11th May 20157:00 amRNSAnnouncement of Final Results
22nd Apr 20157:00 amRNSChange of Adviser
15th Apr 20157:00 amRNSProduction Update & Notice of Results
13th Jan 20157:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.